Stock Movers: Nike Rises on CEO Purchase, Corcept Falls on Drug Rejection, DJT Surges on Crypto Plans

Nike's Stock Surge

• 📈 Nike (NKE) shares increased by approximately 4.5% following CEO Elliot Hill's purchase of about $1 million in company stock.
• 💡 This move by Hill, who also doubled his personal stake, signals confidence in Nike's turnaround strategy, despite the company's year-to-date stock decline of over 15% due to weaker margins and sales in China.

Corcept's Drug Rejection

• 📉 Corcept Therapeutics (CORT) experienced a significant drop of nearly 50%, reaching its lowest point since 2024.
• ⚠️ The decline occurred after US regulators, specifically the FDA, rejected the company's drug, relacorilant, intended to treat a form of high blood pressure related to excessive cortisol hormone levels.
• 🔬 The FDA cited a lack of sufficient evidence for the drug's effectiveness, stating they could not arrive at a favorable benefit-risk assessment.

Trump Media's Digital Token Plan

• 🚀 Trump Media and Technology Group (DJT) saw its shares rise on news of its plan to issue a new digital token in partnership with Crypto.com.
• 💰 Shareholders will receive one DJT share for every token they hold, with further details expected next year and potential for periodic rewards.
• 📊 This announcement comes despite the company reporting an operating loss of $186 million and generating only $3.7 million in revenue over the last 12 months, and notably, it lacks analyst price targets or earnings forecasts.

Broader Market Trends

• 🐂 The S&P 500 is up 17% this year, entering the fourth year of a bull market, with the AI rally broadening beyond just Nvidia.
• 💾 Companies like SanDisk (up 600%) and Western Digital are benefiting significantly from the AI trend, reflecting a shift in market leadership.